华厦眼科(301267)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

301267 华厦眼科

已收盘 05-15 15:00:00

{"stockData":{"symbol":"301267","market":"SZ","secType":"STK","nameCN":"华厦眼科","latestPrice":17.34,"timestamp":1778828637000,"preClose":17.59,"halted":0,"volume":4036118,"delay":0,"changeRate":-0.0142,"floatShares":648000000,"shares":840000000,"eps":0.5508,"marketStatus":"已收盘","change":-0.25,"latestTime":"05-15 15:00:00","open":17.57,"high":17.89,"low":17.26,"amount":70641300,"amplitude":0.0358,"askPrice":17.34,"askSize":85,"bidPrice":17.33,"bidSize":92,"shortable":0,"etf":0,"ttmEps":0.5508,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1779067800000},"marketStatusCode":5,"adr":0,"adjPreClose":17.59,"symbolType":"stock","openAndCloseTimeList":[[1778808600000,1778815800000],[1778821200000,1778828400000]],"highLimit":19.35,"lowLimit":15.83,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":840000000,"isCdr":false,"pbRate":2.72,"roa":"--","peRate":31.481481,"roe":"3.15%","epsLYR":0.53,"committee":-0.519856,"marketValue":14566000000,"turnoverRate":0.0062,"status":1,"floatMarketCap":11244000000},"requestUrl":"/m/hq/s/301267/wiki","defaultTab":"wiki","newsList":[{"id":"2632608730","title":"每周股票复盘：华厦眼科（301267）Q1净利增14.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632608730","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632608730?lang=zh_cn&edition=full","pubTime":"2026-05-03 08:44","pubTimestamp":1777769050,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，华厦眼科报收于18.19元，较上周的18.14元上涨0.28%。本周，华厦眼科4月28日盘中最高价报18.75元。本周关注点来自业绩披露要点：2026年一季度归母净利润1.72亿元，同比上升14.69%。股本股东变化截至2026年3月31日，华厦眼科股东户数为2.13万户，较2025年12月31日减少1008.0户，减幅4.52%。户均持股数量由3.77万股增至3.95万股，户均持股市值为66.57万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050300002183.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631666510","title":"东吴证券：给予华厦眼科买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2631666510","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631666510?lang=zh_cn&edition=full","pubTime":"2026-04-29 21:43","pubTimestamp":1777470182,"startTime":"0","endTime":"0","summary":"东吴证券股份有限公司朱国广,冉胜男,苏丰近期对华厦眼科进行研究并发布了研究报告《2025年报&2026年一季度点评：26Q1业绩回暖，屈光业务引领增长》，给予华厦眼科买入评级。2025年，公司通过非同一控制下企业合并新增了北京华厦民众眼科医院、宁波鄞州华厦眼科诊所、杭州临平华厦视光诊所等机构，持续扩大服务网络。最新盈利预测明细如下：该股最近90天内共有1家机构给出评级，买入评级1家；过去90天内机构目标均价为23.87。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900066929.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267","601555"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631545565","title":"华厦眼科2025年平稳双增、2026Q1盈利提速：技术+区域协同构筑长期护城河","url":"https://stock-news.laohu8.com/highlight/detail?id=2631545565","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631545565?lang=zh_cn&edition=full","pubTime":"2026-04-29 10:57","pubTimestamp":1777431429,"startTime":"0","endTime":"0","summary":"中国网财经4月29日讯 4月27日晚间，华厦眼科 同步披露2025年年报与2026年一季报。数据显示，2025年公司实现营业收入41.39亿元，同比增长2.78%；归母净利润4.41亿元，同比增长2.80%。迈入2026年一季度，经营质量进一步改善，当期实现营收11.50亿元，同比增长5.22%；归母净利润1.72亿元，同比增长14.69%，利润增速大幅跑赢营收增速。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20260429/32188038.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0236","301267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630949311","title":"图解华厦眼科年报：第四季度单季净利润同比下降9.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630949311","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630949311?lang=zh_cn&edition=full","pubTime":"2026-04-28 02:18","pubTimestamp":1777313917,"startTime":"0","endTime":"0","summary":"证券之星消息，华厦眼科2025年年报显示，当年度公司主营收入41.39亿元，同比上升2.79%；归母净利润4.41亿元，同比上升2.8%；扣非净利润4.25亿元，同比上升4.07%；其中2025年第四季度，公司单季度主营收入8.67亿元，同比上升2.63%；单季度归母净利润700.81万元，同比下降9.91%；单季度扣非净利润199.06万元，同比上升125.59%；负债率27.83%，投资收益4659.74万元，财务费用4748.28万元，毛利率43.31%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800006274.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627449910","title":"华厦眼科：持续与多家保险公司开展深度沟通和合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2627449910","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627449910?lang=zh_cn&edition=full","pubTime":"2026-04-14 20:52","pubTimestamp":1776171139,"startTime":"0","endTime":"0","summary":"证券之星消息，华厦眼科04月13日在投资者关系平台上答复投资者关心的问题。目前，公司正沿着“医险协同、服务患者”的方向稳步推进各项工作。首先是持续与多家保险公司开展深度沟通和合作；其次在理赔服务升级上，我们已联合部分保险公司落地快赔、直赔服务。再次感谢您对华厦眼科的支持！","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041400036393.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622025009","title":"华厦眼科：截至目前公司未收到进一步通知","url":"https://stock-news.laohu8.com/highlight/detail?id=2622025009","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622025009?lang=zh_cn&edition=full","pubTime":"2026-03-25 16:36","pubTimestamp":1774427776,"startTime":"0","endTime":"0","summary":"证券之星消息，华厦眼科03月25日在投资者关系平台上答复投资者关心的问题。请问目前案件处于何种司法阶段？请明确回复相关情况，感谢华厦眼科回复：尊敬的投资者您好，感谢您对华厦眼科的关注。关于董事长的最新情况，截至目前公司未收到进一步通知。如有相关进展，公司定将严格按照相关法律法规的规定及时履行信息披露义务。再次感谢您对华厦眼科的支持！","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032500030899.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620446285","title":"华厦眼科：积极推进眼科医疗服务创新与智慧医疗体系建设","url":"https://stock-news.laohu8.com/highlight/detail?id=2620446285","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620446285?lang=zh_cn&edition=full","pubTime":"2026-03-17 15:07","pubTimestamp":1773731237,"startTime":"0","endTime":"0","summary":"证券之星消息，华厦眼科03月17日在投资者关系平台上答复投资者关心的问题。未来是否会拓展智慧眼科新场景？公司始终关注并积极推进眼科医疗服务创新与智慧医疗体系建设，为患者提供优质、多元化的诊疗服务。目前相关应用尚在逐步探索和落地中，对公司业绩不构成重大影响，敬请投资者注意投资风险。再次感谢您对华厦眼科的支持！","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031700020426.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617509637","title":"华厦眼科：公司将积极谋求战略新突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2617509637","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617509637?lang=zh_cn&edition=full","pubTime":"2026-03-06 11:33","pubTimestamp":1772767985,"startTime":"0","endTime":"0","summary":"证券之星消息，华厦眼科03月05日在投资者关系平台上答复投资者关心的问题。公司始终密切关注资本市场动态，高度重视股东权益。再次感谢您对华厦眼科的支持！","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030600015559.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603603126","title":"华厦眼科（301267）披露董事会换届选举结果，1月15日股价上涨0.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603603126","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603603126?lang=zh_cn&edition=full","pubTime":"2026-01-15 17:40","pubTimestamp":1768470044,"startTime":"0","endTime":"0","summary":"截至2026年1月15日收盘，华厦眼科报收于19.39元，较前一交易日上涨0.05%，最新总市值为162.88亿元。该股当日开盘19.25元，最高19.58元，最低19.18元，成交额达1.15亿元，换手率为0.92%。近日，华厦眼科医院集团股份有限公司发布2026年第一次临时股东会决议公告，公司于2026年1月14日召开2026年第一次临时股东会，审议通过董事会换届选举议案。表决结果均获高票通过，中小股东参与积极。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011500029324.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601053100","title":"华厦眼科：全飞秒SMILE pro手术量突破6,000例","url":"https://stock-news.laohu8.com/highlight/detail?id=2601053100","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601053100?lang=zh_cn&edition=full","pubTime":"2026-01-05 15:21","pubTimestamp":1767597680,"startTime":"0","endTime":"0","summary":"今年5月，公司下属厦门眼科中心、郑州华厦视光眼科医院、成都爱迪眼科医院等5家医院，作为全国首批眼科医疗机构，率先引进蔡司新一代机器人全飞秒VISUMAX 800手术设备及全飞秒SMILE pro手术技术。截至12月6日，上述首批引进设备开展的全飞秒SMILE pro手术量已突破6,000例。其中，厦门眼科中心是全国首家全飞秒SMILE pro手术量突破1000例的医院，也是全球最短时间突破2000例的单体医院。再次感谢您对华厦眼科的支持！","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500015145.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2595276625","title":"股市必读：华厦眼科（301267）12月26日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2595276625","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595276625?lang=zh_cn&edition=full","pubTime":"2025-12-29 03:29","pubTimestamp":1766950150,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，华厦眼科报收于18.21元，下跌0.49%，换手率0.52%，成交量3.34万手，成交额6088.66万元。2025年，公司制订并披露了《未来三年股东分红回报规划》，12月22日实施了中期利润分配，进一步加强股东回报。再次感谢您对华厦眼科的支持！当日关注点来自交易信息汇总：12月26日主力资金净流出374.33万元，散户资金净流入456.29万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122900001240.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2594299853","title":"华厦眼科：累计分红约5.07亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2594299853","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594299853?lang=zh_cn&edition=full","pubTime":"2025-12-26 20:52","pubTimestamp":1766753536,"startTime":"0","endTime":"0","summary":"证券之星消息，华厦眼科12月26日在投资者关系平台上答复投资者关心的问题。上市以来公司每年都实施现金分红，截止目前已累计分红约5.07亿元。此外，2024年公司积极实施股份回购，通过自有资金累计回购公司股份752.78万股，累计成交金额超2亿元。再次感谢您对华厦眼科的支持！","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122600033311.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2594791234","title":"华厦眼科：多措并举积极做好市值管理工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2594791234","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594791234?lang=zh_cn&edition=full","pubTime":"2025-12-25 20:52","pubTimestamp":1766667135,"startTime":"0","endTime":"0","summary":"证券之星消息，华厦眼科12月24日在投资者关系平台上答复投资者关心的问题。二级市场股价受多方面因素影响。尽管面临挑战，公司管理层始终高度重视市值管理与股东回报。未来，公司将继续专注提升经营质量与核心竞争力，并结合实际情况，多措并举积极做好市值管理工作。再次感谢您对华厦眼科的支持！","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122500033410.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2591672222","title":"华厦眼科：引进国际前沿诊疗新技术新设备","url":"https://stock-news.laohu8.com/highlight/detail?id=2591672222","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591672222?lang=zh_cn&edition=full","pubTime":"2025-12-16 11:37","pubTimestamp":1765856233,"startTime":"0","endTime":"0","summary":"证券之星消息，华厦眼科12月16日在投资者关系平台上答复投资者关心的问题。作为国内大型眼科医疗连锁集团，华厦眼科始终秉持“精湛医术、合理收费、高尚医德，贴心服务，快捷方便，优雅环境”的经营理念，持续为患者提供专业、优质、收费合理的诊疗服务。再次感谢您对华厦眼科的支持！","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121600015399.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2591642389","title":"华厦眼科（301267）披露2025年中期分红派息实施公告，12月15日股价下跌0.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591642389","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591642389?lang=zh_cn&edition=full","pubTime":"2025-12-15 22:18","pubTimestamp":1765808302,"startTime":"0","endTime":"0","summary":"截至2025年12月15日收盘，华厦眼科报收于18.33元，较前一交易日下跌0.97%，最新总市值为153.97亿元。该股当日开盘18.39元，最高18.63元，最低18.29元，成交额达1.27亿元，换手率为1.06%。公司近日发布公告，披露2025年中期分红派息实施情况。根据公告，本次分红以公司总股本840,000,000股剔除回购股份7,527,840股后的832,472,160股为基数，向全体股东每10股派发现金红利0.90元（含税），合计派发74,922,494.40元。回购股份不参与分红，分配方案与董事会审议通过的一致。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121500035530.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2589897549","title":"华厦眼科：公司经营一切正常不存在退市风险","url":"https://stock-news.laohu8.com/highlight/detail?id=2589897549","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589897549?lang=zh_cn&edition=full","pubTime":"2025-12-05 20:52","pubTimestamp":1764939145,"startTime":"0","endTime":"0","summary":"证券之星消息，华厦眼科12月05日在投资者关系平台上答复投资者关心的问题。最近公司股价一路下跌，前几天看到证券软件公布的消息，是在2025年12月15日后调出创业板指数。公司经营一切正常，已连续多年保持盈利，上市以来公司每年实施现金分红，且正在实施2025年中期分红，不存在触及退市风险警示及其他风险警示的有关情形。再次感谢您对华厦眼科的支持！","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120500037038.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2588884162","title":"华厦眼科：通过自建及并购推进全国布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2588884162","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588884162?lang=zh_cn&edition=full","pubTime":"2025-12-04 20:51","pubTimestamp":1764852696,"startTime":"0","endTime":"0","summary":"证券之星消息，华厦眼科(301267)12月03日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘：您好！请问公司线下的实体店的盈利模式是加盟的合作方式还是直营。华厦眼科回复：尊敬的投资者您好，感谢您对华厦眼科的关注。公司长期专注于眼科医疗服务，已经建立了全国连锁运营的诊疗服务体系。公司正按照发展战略规划，通过自建及并购方式，稳步推进全国医疗服务网络布局。再次感谢您对华厦眼科的支持！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120400036925.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2588087475","title":"华厦眼科：构建完善近视防控体系","url":"https://stock-news.laohu8.com/highlight/detail?id=2588087475","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588087475?lang=zh_cn&edition=full","pubTime":"2025-12-02 15:12","pubTimestamp":1764659526,"startTime":"0","endTime":"0","summary":"证券之星消息，华厦眼科12月02日在投资者关系平台上答复投资者关心的问题。公司拥有由国际眼科科学院院士赵堪兴教授领衔的高水平专家团队，在儿童青少年常见及疑难眼病、儿童青少年近视防控领域具备丰富的临床经验。再次感谢您对华厦眼科的支持！","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120200016984.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301267","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516645761","title":"华厦眼科：有关董事长目前的最新情况，请查阅公司于2024年6月6日披露的相关公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2516645761","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516645761?lang=zh_cn&edition=full","pubTime":"2025-03-04 15:30","pubTimestamp":1741073438,"startTime":"0","endTime":"0","summary":"证券之星消息，华厦眼科03月04日在投资者关系平台上答复投资者关心的问题。有关董事长目前的最新情况，请查阅公司于2024年6月6日披露的相关公告。若有进一步信息，公司将及时履行信披义务。再次感谢您对华厦眼科的支持！","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030400020849.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514406433","title":"华厦眼科收盘下跌1.22%，滚动市盈率29.67倍，总市值157.08亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514406433","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514406433?lang=zh_cn&edition=full","pubTime":"2025-02-25 18:41","pubTimestamp":1740480063,"startTime":"0","endTime":"0","summary":"2月25日，华厦眼科今日收盘18.7元，下跌1.22%，滚动市盈率PE达到29.67倍，总市值157.08亿元。从行业市盈率排名来看，公司所处的医疗服务行业市盈率平均48.80倍，行业中值45.66倍，华厦眼科排名第21位。截至2024年三季报，共有2家机构持仓华厦眼科，其中基金2家，合计持股数4.21万股，持股市值0.01亿元。华厦眼科医院集团股份有限公司主营业务为眼科医疗服务，向眼科疾病患者提供各种眼科疾病的诊断、治疗等眼科医疗服务。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/25184148377123.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["301267","BK0236"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1778978734028,"stockEarnings":[{"period":"1week","weight":-0.0388},{"period":"1month","weight":0.0093},{"period":"3month","weight":-0.0632},{"period":"6month","weight":-0.1463},{"period":"1year","weight":-0.0789},{"period":"ytd","weight":-0.0356}],"compareEarnings":[{"period":"1week","weight":-0.0107},{"period":"1month","weight":0.0269},{"period":"3month","weight":0.0131},{"period":"6month","weight":0.0363},{"period":"1year","weight":0.2232},{"period":"ytd","weight":0.042}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"华厦眼科医院集团股份有限公司","boardCode":"AI0083","boardName":"卫生","stockholders":"21273人(较上一季度减少4.52%)","perCapita":"30482股","listingDate":"2022-11-07","address":"福建省厦门市湖里区五通西路999号之1701","registeredCapital":"84000万元","survey":"　　华厦眼科医院集团股份有限公司的主营业务是眼科专科医疗服务。公司的主要产品是白内障项目、眼后段项目、屈光项目、眼视光综合项目。","listedPrice":50.88},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华厦眼科(301267)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华厦眼科(301267)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华厦眼科,301267,华厦眼科股票,华厦眼科股票老虎,华厦眼科股票老虎国际,华厦眼科行情,华厦眼科股票行情,华厦眼科股价,华厦眼科股市,华厦眼科股票价格,华厦眼科股票交易,华厦眼科股票购买,华厦眼科股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华厦眼科(301267)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华厦眼科(301267)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}